An individualized comprehensive care package for acute exacerbation of chronic obstructive pulmonary disease patients reduces 90-day mortality.
Although a “need-based” individualized comprehensive care package for people admitted to hospitals for acute exacerbation of chronic obstructive pulmonary disease (COPD) did not reduce 30- and 90-day readmission rates in all patients, it did reduce 90-day total mortality and also reduced 90-day readmission rates in women. The study, by Simon L. Adamson, and colleagues, was published in the International Journal of COPD.
Acute exacerbation of COPD, characterized by a sudden worsening of patients’ respiratory symptoms, such as shortness of breath, cough, and sputum production, is associated with increased COPD morbidity and mortality. Acute exacerbation of COPD also decreases quality of life, accelerates lung function decline, and is associated with significant healthcare costs. Since patients with COPD experience the greatest number of readmissions to acute hospital care and the emergency department of any patient group, reducing acute exacerbation of COPD and reducing hospital readmissions are primary goals of COPD management.
The authors retrospectively reviewed data of patients admitted for acute exacerbation of COPD to 2 inner-city teaching hospitals to determine the impact of a comprehensive and individualized care management strategy on readmissions for acute exacerbation of COPD. The experimental group (191 patients) received comprehensive care targeted to the sensitive time period (2-4 weeks) immediately following a hospitalization due to acute exacerbation of COPD; 271 patients were controls. The total number of readmissions in 30 and 90 days after index hospitalization were measured, and the length of time between index admission and first readmission and all-cause mortality were secondary outcomes.
The 2 groups were similar in terms of age, sex, forced expiratory volume in 1 second, body mass index, pack-years smoked, and number and types of comorbidities. Comprehensive care significantly reduced 90-day readmission rates in females (P = .0205) but not in males or in the whole group. Average times between index admission and first readmission were not different between the 2 groups. The 90-day all-cause in-hospital mortality rates were significantly less in the care package group (2.67% vs 7.97%, P = .0268).
A larger randomized trial is needed to tease out which aspects of the comprehensive plan are more effective in improving patient outcomes, the authors note.
“We suspect that better and earlier recognition of exacerbations, improved self-management techniques, and availability of an outreach team in the community could have contributed to the beneficial effects of the intervention after [acute exacerbation of] COPD,” they concluded.
Could On-Body Delivery of Isatuximab Bring More Competition to Anti-CD38 Myeloma Treatment?
June 6th 2025Results for IRAKLIA show noninferiority for Sanofi's on-body delivery system for isatuximab, compared with IV administration. Patients overwhelmingly preferred the hands-free delivery option.
Read More
ICS Use Tied to Fewer Exacerbations in Patients With Bronchiectasis and Elevated Blood Eosinophils
June 6th 2025Inhaled corticosteroid (ICS) use was common among patients with bronchiectasis and was associated with reduced exacerbations and hospitalizations in those with elevated blood eosinophil counts.
Read More
Real-World Data Support Luspatercept vs ESAs for Anemia in Lower-Risk MDS
June 5th 2025Patients with myelodysplastic syndrome (MDS) who received luspatercept showed greater hemoglobin gains and transfusion independence compared with erythropoiesis-stimulating agents (ESAs) in a real-world analysis.
Read More
At EHA 2025, Hematology Discussions Will Stretch Across Lifespans and Locations
June 5th 2025The 2025 European Hematology Association (EHA) Congress, convening virtually and in Milan, Italy, from June 12 to June 15, 2025, will feature a revamped program structure for the meeting’s 30th anniversary while maintaining ample opportunities to network, debate, and absorb practice-changing findings in hematology and oncology.
Read More